Clinical impact of glycated albumin as another glycemic control marker

Relationship between Clinical Markers of Glycemia and Glucose Excursion Evaluated by Continuous Glucose Monitoring (CGM).

(2010) Tomoko SUWA et al.   ENDOCRINE JOURNAL

Serum glycated albumin to haemoglobin A1C ratio can distinguish fulminant type 1 diabetes mellitus from type 2 diabetes mellitus

(2010) M. Koga et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Serum glycated albumin, but not glycated haemoglobin, is low in relation to glycemia in hyperuricemic men

(2009) Masafumi Koga et al.   ACTA DIABETOLOGICA

Glycated albumin levels are higher relative to glycated haemoglobin levels in gastrectomized subjects

(2009) M. Koga et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver disease

(2009) Y. Bando et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Serum glycated albumin levels are influenced by smoking status, independent of plasma glucose levels

(2008) Masafumi Koga et al.   ACTA DIABETOLOGICA

CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases

(2008) Masafumi Koga et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Glycated Albumin is a Better Indicator for Glucose Excursion than Glycated Hemoglobin in Type 1 and Type 2 Diabetes

(2008) Kazutomi YOSHIUCHI et al.   ENDOCRINE JOURNAL

Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis

(2007) KOUSUKE FUKUOKA et al.   NEPHROLOGY